Global Equine Rabies Immunoglobulin (ERIG) Market Size Analysis 2022, Top Regions, Key Players and Investments Opportunities Forecast to 2028

The equine rabies immunoglobulin (ERIG) market is anticipated to grow at a significant CAGR of 4.4% during the forecast period (2022-2028). ERIG is a hyperimmune globulin made from persons who have been inoculated against rabies and have extremely high antibody titers. The ERIG is used to treat people who have been exposed to rabid animals. The major factor driving the growth of the market includes the rising prevalence of rabies globally. According to World Health Organization (WHO), rabies is a viral illness that may be prevented by vaccination and is found in over 150 nations and territories. Dogs are the primary cause of human rabies mortality, accounting for up to 99% of all human rabies transmissions. Interrupting transmission can be accomplished by vaccinating dogs and avoiding dog bites. Every year, the illness kills tens of thousands of people, mostly in Asia and Africa.

Scope of the Equine Rabies Immunoglobulin (ERIG) Report

The research study analyzes the Equine Rabies Immunoglobulin (ERIG) industry from a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis

o Import and Export Overview

o Volume Analysis

o Current Market Trends and Future Outlook

o Market Opportunistic and Attractive Investment Segment

Equine Rabies Immunoglobulin (ERIG) Market Segmentation:

By Type

• 1500IU
• 1000IU
• 400IU

Competitive Landscape- CSL Behring, Grifols SA, Sanofi SA, and Sun Pharmaceuticals Co. Ltd., among others.

Geographic Coverage

o North America Market Size and/or Volume

o Latin America Market Size and/or Volume

o Europe Market Size and/or Volume

o Asia-Pacific Market Size and/or Volume

o Rest of the world Market Size and/or Volume

Key questions answered in this report:

• What is the size of the Equine Rabies Immunoglobulin (ERIG) market and what is its expected growth rate?
• What are the primary driving factors that push the Equine Rabies Immunoglobulin (ERIG) Market forward?
• What are the Equine Rabies Immunoglobulin (ERIG) Industry’s top companies?
• What are the different categories that the Equine Rabies Immunoglobulin (ERIG) Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Equine Rabies Immunoglobulin (ERIG) Market sample report and company profiles?